Skip to main content

and
  1. No Access

    Chapter

    Komorbiditäten

    Daten zur Komorbidität bei medikamentenbezogenen Störungen liegen nach Kenntnis der Autor*innen für Deutschland nicht ausreichend vor.

    Ulrich Preuss, Stefan Cohrs in S3-Leitlinie Medikamentenbezogene Störungen (2022)

  2. No Access

    Article

    Cannabis-basierte Arzneimittel bei psychischen Störungen

    PD Dr. rer. nat. Eva Hoch, Prof. Dr. med. Oliver Pogarell in MMW - Fortschritte der Medizin (2020)

  3. No Access

    Chapter

    Cannabiskonsum zum Freizeitgebrauch

    Zur gezielten Aufnahme, Verarbeitung und Speicherung der komplexen sensorischen Informationen unserer Umwelt benötigen wir kognitive Fähigkeiten. Unter „Kognition” versteht man dabei eine Vielzahl bewusster so...

    Miriam Schneider, Chris Maria Friemel, Rupert von Keller in Cannabis: Potenzial und Risiko (2019)

  4. No Access

    Chapter

    Wirksamkeit, Verträglichkeit und Sicherheit von medizinischem Cannabis

    Viele Erkrankungen können von konstanten oder intermittierenden, anhaltenden Schmerzen begleitet werden. Dies ist beispielsweise häufig der Fall bei Krebserkrankungen, multipler Sklerose (MS) (Abschn. 4.2 und ...

    Eva Hoch, Miriam Schneider, Rupert von Keller, Udo Bonnet in Cannabis: Potenzial und Risiko (2019)

  5. No Access

    Article

    Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders

    Liability to alcohol dependence (AD) is heritable, but little is known about its complex polygenic architecture or its genetic relationship with other disorders. To discover loci associated with AD and charact...

    Raymond K. Walters, Renato Polimanti, Emma C. Johnson in Nature Neuroscience (2018)

  6. No Access

    Article

    Cognitive Efficacy of Quetiapine in Early-Onset First-Episode Psychosis: A 12-Week Open Label Trial

    Twenty-three adolescents with psychotic disorders, aged from 13 to 18 years, participated in a 12-week open label trial (17 adolescents completed the study) in order to examine the impact of quetiapine on clin...

    Sébastien Urben, Pierre Baumann, Sandra Barcellona, Muriel Hafil in Psychiatric Quarterly (2012)

  7. Article

    Open Access

    Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey

    Children with attention-deficit/hyperactivity disorder (ADHD) often experience problems with education, interaction with others and emotional disturbances. Families of ADHD children also suffer a significant b...

    David Coghill, Cesar Soutullo in Child and Adolescent Psychiatry and Mental… (2008)

  8. No Access

    Article

    Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment

    To describe the associations between a range of baseline factors (demographic, family and clinical) and parent-reported health-related quality of life (HRQoL) of children with ADHD taking part in the ADORE study.

    Prof. Anne W. Riley PhD, Georg Spiel in European Child & Adolescent Psychiatry (2006)

  9. No Access

    Chapter

    Poster

    Objective: One of the most powerful medications that have very broad aspects of clinical application are the selective serotonin reuptake inhibitors (SSRI). We use SSRI as a first choice agents in tr...

    Olivera Aleksic, Milica Pejovic-Milovancevic in Books of Abstracts of the 16th World Congr… (2004)

  10. No Access

    Chapter

    Symposia

    Goal: The goal of this symposium is to identify ‘state-of-the-art’ strategies for the use of antipsychotic medications in the management of children and adolescents with major psychiatric disorders. Learning o...

    Christoph Correll, Stanley P. Kutcher in Books of Abstracts of the 16th World Congr… (2004)

  11. No Access

    Article

    Use of Acamprosate and Different Kinds of Psychosocial Support in Relapse Prevention of Alcoholism

    Objective: To determine abstinence rates and to obtain safety data during the use of integrated therapy with acamprosate and the main established psychotherapeutic intervention programmes in the ...

    Dr Michael Soyka, Ulrich Preuss, Christian Schuetz in Drugs in R & D (2002)

  12. No Access

    Article

    Dipole Localization of P300 and Normal Aging

    At present, our understanding of how normal aging affects in vivo brain function is rudimentary. Therefore, the aim of the present study was to investigate age effects on auditory P300 topography. A recently d...

    Thomas Frodl, Georg Juckel, Jürgen Gallinat, Ronald Bottlender in Brain Topography (2000)